指南与共识哮喘慢阻肺

吸入药物的环境影响:澳大利亚与新西兰胸科学会立场声明

Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement.
指南 / 共识 · Respirology · 2024-11-13

TSANZ工作组综述了吸入药物对气候变化的影响,并提出通过准确诊断、更好控制疾病和选择低环境影响装置来减少环境影响的策略。

要点

  • pMDI推进剂全球变暖潜能极高,是医疗相关温室气体主要来源之一。
  • 准确诊断避免不必要治疗,良好疾病控制减少缓解药需求。
  • 临床允许时主动选择环境影响更低的吸入装置,并个体化权衡。

核心结论

  • 吸入药物对环境有显著影响,医务人员和消费者应采取策略减少气道疾病管理中的环境足迹。

研究设计与样本

  • TSANZ工作组立场声明,综述澳大利亚与新西兰吸入药物使用及其对气候变化和环境退化的贡献。

主要发现

  • 澳大利亚与新西兰pMDI是主要处方装置,沙丁胺醇pMDI在澳大利亚可非处方购买。
  • pMDI所含推进剂具有极高全球变暖潜能,是医疗相关温室气体主要贡献者。

关键数值与推荐

  • 建议准确诊断以避免不必要治疗。
  • 建议更好控制疾病以最小化缓解治疗需求。
  • 建议临床适当时主动选择环境影响更低的吸入装置。
  • 吸入装置选择应个体化,考虑手部灵活度、吸气能力和费用等因素。

临床怎么用

  • 临床选吸入装置时应在保证最佳临床结局前提下,结合手部灵活度、吸气能力和费用并考虑环境影响。
  • 通过准确诊断和优化疾病控制减少缓解药使用,从而降低环境足迹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally, more than 1.2 billion inhalers are purchased for asthma and chronic obstructive pulmonary disease (COPD) annually. In Australia and New Zealand, pressurized metered dose inhalers (pMDIs) are the leading delivery device prescribed and pMDI salbutamol can be purchased over the counter in Australia. These inhalers are a major contributor to healthcare related greenhouse gases. This is due to the propellants that they currently contain which have extremely high global warming potential (GWP). In this position paper, we report the findings of a Thoracic Society of Australia and New Zealand (TSANZ) working group on the environmental impact of inhaled respiratory medicines. We reviewed the use of inhaled medicines in Australia and New Zealand and their contribution to climate change and other environmental degradation. We propose strategies for health professionals and consumers to reduce environmental impact in the management of airway diseases. These include accurate diagnosis to avoid unnecessary treatment, better disease control to minimize the need for reliever therapy and actively choosing inhaler devices with lower environmental impacts when clinically appropriate. Inhaler selection should be tailored to the individual, aiming to achieve the best possible clinical outcome. Choosing an appropriate inhaler for an individual involves consideration of factors such as dexterity, inspiratory capacity and cost. In our current climate emergency and with the availability of lower carbon alternatives, health professionals should also consider environmental impact.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Wurzel, Montgomery, Anderson, et al. Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement. Respirology. 2024. PMID: 39536776. doi:10.1111/resp.14852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。